1. Resveratrol treatment may preserve the erectile function after radiotherapy by restoring antioxidant defence mechanisms, SIRT1 and NOS protein expressions
- Author
-
Göksel Şener, Ozge Cevik, Ilker Tinay, Ferruh Şimşek, Beste M. Atasoy, Özlem Tuğçe Çilingir Kaya, Şule Çetinel, Cem Akbal, Ayse Dagli Degerli, Salvatore Butticè, Hasan Hüseyin Tavukçu, Tarik Emre Sener, [Sener, Tarik Emre -- Tinay, Ilker -- Simsek, Ferruh] Marmara Univ, Sch Med, Dept Urol, Istanbul, Turkey -- [Tavukcu, Hasan Huseyin] Istanbul Bilim Univ, Dept Urol, Istanbul Florence Nightingale Hosp, Istanbul, Turkey -- [Atasoy, Beste Melek -- Degerli, Ayse Dagli] Marmara Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey -- [Cevik, Ozge] Cumhuriyet Univ, Sch Pharm, Dept Biochem, Sivas, Turkey -- [Kaya, Ozlem Tugce -- Cetinel, Sule] Marmara Univ, Sch Med, Dept Histol & Embryol, Istanbul, Turkey -- [Akbal, Cem] Acibadem Univ, Sch Med, Dept Urol, Istanbul, Turkey -- [Buttice, Salvatore] San Giovanni di Dio Hosp, Dept Urol, Agrigento, Italy -- [Sener, Goksel] Marmara Univ, Sch Pharm, Dept Pharmacol, Istanbul, Turkey, Atasoy, Beste -- 0000-0003-1320-9105, Akbal, Cem -- 0000-0003-2202-6909, Cilingir Kaya, Ozlem Tugce -- 0000-0002-2591-9174, and Cevik, Ozge -- 0000-0002-9325-3757
- Subjects
Male ,Antioxidant ,Nitric Oxide Synthase Type III ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,Resveratrol ,Pharmacology ,Nitric Oxide ,medicine.disease_cause ,Antioxidants ,Nitric oxide ,Superoxide dismutase ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Erectile Dysfunction ,Sirtuin 1 ,Enos ,medicine ,Animals ,Rats, Wistar ,Cyclic guanosine monophosphate ,Radiotherapy ,biology ,Superoxide Dismutase ,business.industry ,Penile Erection ,Forkhead Box Protein O3 ,Glutathione ,biology.organism_classification ,Rats ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,business ,Oxidative stress ,Penis - Abstract
WOS: 000443568400006, PubMed ID: 29973698, Radiotherapy (RT) for prostate cancer (PC) can cause erectile dysfunction (ED) by damaging neurovascular structures with oxidative stress. In this study, we evaluated the effects of resveratrol, an antioxidant, on post-RT ED. Fifty rats in five groups were evaluated; control (C), prostate-confined radiotherapy with short- and long-term vehicle or resveratrol treatment. Cavernosal tissues were obtained to analyze glutathione (GSH), nitric oxide (NO), cyclic guanosine monophosphate (cGMP), 8-hydroxy-2'-deoxy-guanosine (8-OHdG) levels and superoxide dismutase (SOD), caspase-3 activities, sirtuin-1, Foxo-3, nNOS, and eNOS protein expressions. Intracavernosal pressures (ICP) were measured for the long-term treatment group. In the RT long-term vehicle treatment group, tissue GSH, NO, cGMP, and SOD activity were decreased while 8-OHdg levels and caspase-3 activities were increased. Radiotherapy caused a decrease in sirtuin-1, nNOS, and eNOS protein expressions. These parameters were reversed by resveratrol treatment. Foxo-3 protein expressions were unaltered in the RT + short-term vehicle treatment group and started to increase as a defense mechanism in the RT long-term vehicle group; however, resveratrol treatment caused a significant increase in Foxo-3 expressions. Resveratrol preserved the metabolic pathways involved in erectile function and provided functional protection. Resveratrol can be used as a supplementary agent in patients undergoing radiotherapy to preserve erectile function., Marmara University Scientific Research Projects Committee [SAG-B-100914-0311], This study was supported by Marmara University Scientific Research Projects Committee with the grant number SAG-B-100914-0311.
- Published
- 2018